Tag: chronic lower back pain market insights

  • 2024-2033 Chronic Lower Back Pain Market Forecast: Predicted Growth Rate and Market Size

    2024-2033 Chronic Lower Back Pain Market Forecast: Predicted Growth Rate and Market Size

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Rapidly is the Chronic Lower Back Pain Market Forecasted to Grow Between 2024 and 2033?

    The market size for chronic lower back pain has experienced robust growth in the past few years. There’s an expected growth from $7.3 billion in 2023 to $7.67 billion in 2024, showing a compound annual growth rate (CAGR) of 5.1%. The historical growth of this market can be linked to factors like sedentary lifestyles, risks associated with manual labor and occupations, advances in medical diagnosis, the progress of pain management techniques, and valuable insights from epidemiological studies.

    During the upcoming years, the market size for chronic lower back pain is predicted to progressively expand. The expected growth rate is set to reach $9.27 billion in 2028, projecting a compound annual growth rate (CAGR) of 4.9%. This anticipated expansion over the forecast period is accredited to the increasing implementation of non-pharmacological interventions, the promotion of preventive healthcare programs, the concentration on comprehensive therapies, advances in regenerative medicine, and the aging population pattern. Significant trends for the forecast period encompass a focus on non-pharmacological treatments, an alteration in pain management techniques, initiatives on healthcare cognizance and education, the advancement in telemedicine and remote patient monitoring, and the incorporation of regenerative medicine.

    Claim Your Free Sample of the Global Chronic Lower Back Pain Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp

    What Factors Are Behind the Rapid Growth of the chronic lower back pain Market?

    The chronic lower back pain market is likely to experience significant growth as the frequency of nerve instances increases. These instances are defined as situations whereby an individual shows strength or perseverance amidst tough or frightening situations. Prolonged exposure to stress and pain could cause a condition known as central sensitization, wherein the nervous system becomes excessively sensitive and perceives pain more severely, even without an actual injury. For example, a report from the UK-based weekly scientific journal, Nature, in July 2023, indicated that peripheral neuropathy, connected to nerve damage, had a prevalence rate of 28.4% in diabetic adults aged 40 or above, and 11.8% in non-diabetic individuals. Hence, the rise in the frequency of nerve instances is fuelling the expansion of the chronic lower back pain market.

    What Are the Principal Segments of the Chronic Lower Back Pain Market?

    1) By Type of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain

    2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment of Pain

    3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users

    What Emerging Patterns Are Redefining the Chronic Lower Back Pain Market?

    Leading corporations in the chronic lower back pain industry are prioritizing the development of innovative pharmaceuticals for their clientele to maintain their hold on the market. The invention of new treatments can enhance the success rate among patients suffering from various ailments. For example, Amneal Pharmaceuticals, an American pharmaceutical firm, introduced LYVISPAH, an orally administered baclofen granule (5, 10, and 20 mg) in July 2022. The U.S. FDA approved this drug for managing spasticity that’s linked to multiple sclerosis and other spinal cord disorders. LYVISPAH aids in treating flexor spasms and linked pain, clonus, and muscle stiffness. It offers personalized dosage with single-use granule packages in doses of 5 mg, 10 mg, and 20 mg, and has the same bioequivalence as oral baclofen tablets. Those with spinal cord injuries and other related diseases might also find LYVISPAH beneficial.

    Order Now for Fast Delivery of Your Chronic Lower Back Pain Market Report!

    https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

    Which Geographical Regions Are Shaping the Chronic Lower Back Pain Market Growth?

    North America was the largest region in the chronic lower back pain market in 2023. The regions covered in the chronic lower back pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Chronic Lower Back Pain Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the chronic lower back pain market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Chronic Lower Back Pain Market Include

    1. Chronic Lower Back Pain Market Executive Summary

    2. Chronic Lower Back Pain Market Segments

    3. Chronic Lower Back Pain Market Size And Template Market Growth Rate

    4. Key Chronic Lower Back Pain Market Trends

    5. Major Chronic Lower Back Pain Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Chronic Lower Back Pain Market

    26. Top Chronic Lower Back Pain Companies

    27. Chronic Lower Back Pain Market Opportunities And Strategies

    28. Chronic Lower Back Pain Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Growth Forecast For The Chronic Lower Back Pain Global Market 2024-2033

    Future Growth Forecast For The Chronic Lower Back Pain Global Market 2024-2033

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Understanding the Market Dynamics

    • Chronic lower back pain market size experienced robust growth.
    • Growth factors include sedentary lifestyles, manual labor risks, and medical advancements.
    • Market size projected to reach $7.67 billion in 2024 with a 5.1% CAGR.

    The Path Ahead: Projections and Trends

    • Expected steady growth to $9.27 billion in 2028 with a 4.9% CAGR.
    • Non-pharmacological interventions, regenerative medicine, and aging population drive growth.
    • Major trends include holistic treatments, telemedicine, and regenerative medicine integration.

    Nerve Instances and Market Growth

    • Increase in nerve instances impacts chronic lower back pain market.
    • Nerve instances lead to central sensitization, intensifying pain perception.
    • Companies driving market growth include Pfizer, Johnson & Johnson, and Sanofi.

    Rising Focus on Advanced Drug Development

    • Major companies prioritize innovative drug development.
    • Example: Amneal Pharmaceuticals’ LYVISPAH for spasticity treatment.
    • New drugs improve treatment outcomes and sustain market position.

    NSF and UC San Diego’s Innovative Collaboration

    • $1.2 million NSF investment in collaboration with UC San Diego.
    • Aims to study and inform chronic low back pain treatment.
    • Focus on remote monitoring and individualized physical therapy treatments.

    Segmentation Insights

    1. By Type of Pain: Diskogenic, Lumbar Spinal Stenosis, Sacroiliac, Facet-Joint, Radicular, Muscular, Others.
    2. By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Pain Assessment.
    3. By End-User: Hospitals, Orthopaedic Clinics, Ambulatory Surgery Centers, Others.

    Regional Insights

    • North America led the chronic lower back pain market in 2023.

    Conclusion: Shaping the Future of Chronic Lower Back Pain Treatment

    The chronic lower back pain market’s trajectory reflects a convergence of medical advancements, demographic shifts, and innovative treatments. As the market continues to evolve, the emphasis on non-pharmacological interventions, advanced drug development, and collaborative research endeavors will define its landscape. With stakeholders committed to addressing the complexities of chronic lower back pain, the journey towards improved patient outcomes and enhanced quality of life gains momentum.

    View More On The Chronic Lower Back Pain Market Report 2024 – https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

    Request A Sample Of The Global Chronic Lower Back Pain Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9946&type=smp